UncategorizedFYR lands funding to find new biomarkers for Parkinson’s Empower Meds / September 26, 2025
UncategorizedAspen Neuroscience begins third cohort in ASPIRO trial – Longevity.Technology Empower Meds / September 26, 2025
UncategorizedNew study backs C2N’s PrecivityAD2 test in symptomatic patients – Longevity.Technology Empower Meds / September 26, 2025
UncategorizedDesigns for Health launches Anaerostipes Probiotic to enhance gut health – Longevity.Technology Empower Meds / September 26, 2025
UncategorizedYouthBio secures FDA INTERACT feedback for YB002 Alzheimer’s gene therapy – Longevity.Technology Empower Meds / September 26, 2025
UncategorizedEpirium Bio reports positive Phase 1 results for MF-300 in healthy volunteers – Longevity.Technology Empower Meds / September 26, 2025
UncategorizedStanford AI course to democratize participation in longevity science Empower Meds / September 25, 2025
UncategorizedFirst partial epigenetic reprogramming therapy for the brain? Empower Meds / September 25, 2025
UncategorizedStratos Health, Superpower partner to offer zero-cost preventive care – Longevity.Technology Empower Meds / September 25, 2025
